Skip to main content
. Author manuscript; available in PMC: 2022 Nov 30.
Published in final edited form as: Mayo Clin Proc. 2019 Aug 7;94(9):1799–1806. doi: 10.1016/j.mayocp.2019.02.027

Table 3.

Subgroup Analysis Limiting to Patients With Available Ascitic Protein Fluid Levelsa

Variable Odds ratio for whole group (95% CI) Odds ratio for subgroup (95% CI)
MELD score 1.20 (1.14-1.26) NA
Ascitic fluid protein NA 0.88 (0.70-1.11)
Age, years 0.99 (0.97-1.03) 1.01 (0.98-1.03)
Females vs males 1.65 (0.87-3.15) 1.41 (0.80-2.49)
Center A vs center C 0.68 (0.34-1.36) 0.75 (0.40-1.39)
Center B vs center C 0.72 (0.33-1.60) 1.26 (0.63-2.53)
a

Center A = University of Texas Medical Branch, Galveston; Center B = University of Alabama at Birmingham; Center C = Mayo Clinic, Rochester, MN; MELD = model for end-stage liver disease; NA = not available.